A small molecule drug conjugate (SMDC) of DUPA and a duocarmycin built on the solid phase

A SMDC is delivered to GCPII, an important cancer target. The payload is released by enzymes overexpressed in cancer cell lines. The SMDC relies on GCPII expression for efficacy.